WALTHAM, Mass., February 25, 2025--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO) ("Thermo Fisher"), the world leader in serving science, today announced that the company has entered ...

On the heels of a move to reduce its viral vector manufacturing workforce, Thermo Fisher is beefing up its biologics production business through a $4.1 billion acquisition. The buyout target is ...

(Reuters) -Contract drug manufacturer Thermo Fisher Scientific said on Tuesday it will buy Solventum's purification and filtration business for about $4.1 billion, sending the latter's shares up ...

Highly Complementary to Thermo Fisher’s Bioproduction Business and Strengthens Offering in the High Growth Bioprocessing Market Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher ...

Thermo Fisher said it is paying about $4.1 billion in cash for the business. The Journal reported in October that Solventum, the healthcare company spun off from 3M last year, had retained bankers ...

The business, which provides filters for the purification of food or beverages and drugs during development, brought in about $1 billion in revenue in 2024, Thermo said. Evercore analyst Vijay ...

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia ...

Thermo Fisher Scientific agreed to pay about $4.1 billion in cash to acquire Solventum’s purification and filtration business. The technologies, used in the production of biologics and medical devices ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...